The thermal denaturation of poliovirus virions and procapsids in the 42 to 48 °C range was studied using N- and H-specific monoclonal antibodies. The half-life of the N antigen of Mahoney and Sabin 1 virions was extended 50- to 250-fold by either 10 µm WIN 51711 or R 78206. The minimum concentrations required for full stabilization at 46 °C (1.0 µm for WIN 51711, 0.2 µm for R 78206) were independent of the strain or serotype of the virus; 30 to 60 molecules of stabilizer per virion were required for full protection. R 78206 was the most efficient stabilizer of Mahoney procapsids; the half-life of the N-specific epitopes of these particles at 44 °C was extended from less than 1 min to 1 day.
AndriesK.,
DewindtB.,
De BrabanderM.,
StokbroekxR.,
JanssenP. A. J.1988; In vitro activity of R61837, a new antirhinovirus compound. Archives of Virology 101:155–167
AndriesK.,
DewindtB.,
SnoeksJ.,
WillebrordsR.1989; Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization. Archives of Virology 106:51–61
AndriesK.,
DewindtB.,
SnoeksJ.,
WoutersL.,
MoereelsH.,
LewiP. J.,
JanssenP. A. J.1990; Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. Journal of Virology 64:1117–1123
BauerD. J.,
SelwayJ. W. T.,
BatchelorJ. F.,
TisdaleM.,
CaldwellJ. C.,
YoungD. A. B.1981; 4′, 6-dichloroflavan (BW683C), a new anti-rhinovirus compound. Nature, London 292:369–370
BrioenP.,
SijensR. J.,
VrijsenR.,
RombautB.,
ThomasA. A. M.,
JackersA.,
BoeyeA.1982; Hybridoma antibodies to poliovirus N and H antigen. Archives of Virology 74:325–330
ChapmanM. S.,
MinorI.,
RossmannM. G.,
DianaG. D.,
AndriesK.1991; Human rhinovirus 14 complexed with antiviral compound R 61837. Journal of Molecular Biology 217:455–463
IshitsukaH.,
NinomyaY. N.,
OhsawaC.,
FujiuM.,
SuhuraY.1982; Direct and specific inactivation of rhinovirus by chalcone Ro 09-410. Antimicrobial Agents and Chemotherapy 22:617–621
KoharaM.,
OmataT.,
KamedaA.,
SemlerB. L.,
ItohH.,
WimmerE.,
NomotoA.1985; In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin-1 strain. Journal of Virology 53:786–792
MinorP. D.,
FergusonM.,
EvansD. M. A.,
AlmondJ. W.,
IcenogleJ. P.1986; Antigenic structure of polioviruses of serotypes 1, 2 and 3. Journal of General Virologyv 67:1283–1291
NakanoJ. H.,
HatchM. H.,
ThiemeM. L.,
NottayB.1978; Parameters for differentiating vaccine-derived and wild poliovirus strains. Progress in Medical Virology 2:178–206
OttoM. J.,
FoxM. P.,
FancherM. J.,
KuhrtM. F.,
DianaG. D.,
McKinlayM. A.1985; In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug. Antimicrobial Agents and Chemotherapy 27:883–886
RombautB.,
BoeyeA.1991; In vitro assembly of poliovirus 14S subunits: WIN 51711 stabilization as a model for the antigenicity conferring activity of infected cell extracts. Virology 180:788–792
RombautB.,
VrijsenR.,
BoeyeA.1985; Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus. Journal of General Virology 66:303–307
RombautB.,
BoeyeA.,
FergusonM.,
MinorP. D.,
MosserA.,
RueckertR.1990a; Creation of an antigenic site in poliovirus type 1 by assembly of 14S subunits. Virology 174:305–307
SmithT. J.,
KremerM. J.,
LuoM.,
VriendG.,
ArnoldE.,
KamerG.,
RossmannM. G.,
McKinlayM. A.,
DianaG. D.,
OttoM. J.1986; The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286–1293
VrijsenR.,
RombautB.,
BoeyeA.1983; A simple quantitative protein A micro-immunoprecipitation method; assay of antibodies to the N and H antigens of poliovirus. Journal of Immunological Methods 59:217–220